BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Kexing Biopharm’s GB18 Receives IND Approval in China and U.S. for Cancer Cachexia Treatment

Kexing Biopharm (688136.SH) announced that the National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) applica...

May 30, 2025 | News

Adalvo Inks Licensing Deal with Formosa Pharmaceuticals for Novel Ophthalmic Steroid in Europe and Brazil

Adalvo announces the signing of an exclusive licensing agreement with Formosa Pharmaceuticals for the commercialisation of Clobetasol propio...

May 29, 2025 | News

Huonslab Completes Patient Enrollment for Pivotal Phase 1 Trial of HLB3-002 in South Korea

Phase 1 Pivotal Study in Korea for HLB3-002 Plans to apply for marketing approval with the MFDS by the 2H 2025 -Huonslab Co., Ltd. (&ldq...

May 27, 2025 | News

UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease

Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first admini...

May 26, 2025 | News

Celltrion’s YUFLYMA® Wins Expanded Interchangeability Status for All Humira® Dosage Forms in the U.S.

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar[1] Cellt...

May 26, 2025 | News

DualityBio and Avenzo Receive FDA IND Clearance for Novel EGFR/HER3 Bispecific ADC

Duality Biotherapeutics partner Avenzo Therapeutics, Inc. a clinical-stage biotechnology company developing next-generation oncology therapies, announced c...

May 23, 2025 | News

Minghui Doses First Patient in Phase II Trial of PD-1xVEGF Bispecific and TROP-2 ADC Combo for Advanced NSCLC

Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative therapies in immunology and oncology, announced that ...

May 21, 2025 | News

Gene Solutions and NEWCL Partner to Launch Advanced NGS Laboratory in Taiwan for Prenatal and Oncology Genetic Testing

Gene Solutions, a leader in prenatal and oncology genetic testing, and NEWCL Biomedical Laboratory, Taiwan's pioneering clinical laboratory ...

May 19, 2025 | News

InnoCare Pharma Doses First Patient in Phase II/III Trial of Soficitinib for Vitiligo in China

InnoCare Pharma a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has...

May 19, 2025 | News

Thermo Fisher Scientific Opens Malaysia Commercial HQ to Advance Scientific Innovation in Asia Pacific

Thermo Fisher Scientific, the world leader in serving science, celebrated the grand opening of its new Malaysia Commercial Headquarters in Shah Alam, reinf...

May 19, 2025 | News

Shanghai Ark Biopharmaceutical Announces Positive Phase II Results for AK3280 in Idiopathic Pulmonary Fibrosis

Shanghai Ark Biopharmaceutical Co., Ltd. announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of id...

May 16, 2025 | News

Alamar Biosciences Expands NULISAseq™ CNS Disease Panel 120 to Include Brain-Derived pTau Assays for Alzheimer’s and Tauopathy Research

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the expansion of its NULISAse...

May 16, 2025 | News

Agilent and Ubix Therapeutics Join Forces to Advance Targeted Cancer Therapies in South Korea

Research focuses on targeted protein degradation and antibody-drug conjugate as promising modalities for developing next-generation cancer therapies ...

May 15, 2025 | News

Thermo Fisher Launches High-Speed, NoSpin Plasmid DNA Kit to Eliminate Bottlenecks in Therapeutic Research

Thermo Fisher Scientific has introduced the Applied Biosystems™ MagMAX™ Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rap...

May 14, 2025 | News

Stay Connected